title: Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease.
abstract: Crohn's disease and ulcerative colitis are chronic relapsing gastrointestinal conditions characterised by an influx of inflammatory cells to the affected gut mucosa. The mainstay of diagnosing and re-evaluating these conditions in clinical practice and research is by invasive serological, radiological, endoscopic and histological assessment. In clinical trials, disease activity is often evaluated using a combination of the above tests plus clinical indices such as the Crohn's Disease Activity Index and Ulcerative Colitis Activity Index. These tools rely on subjective assessment of symptoms and so, often, do not correlate with mucosal inflammation or mucosal healing, which may be the preferred therapeutic end point for long-term inflammatory bowel disease (IBD) management. The faecal biomarkers calprotectin and lactoferrin are neutrophil derived proteins that are stable in faeces and can be detected by quantitative ELISA in small stool samples. Concentrations of both are raised in patients with gastrointestinal mucosal inflammation. They provide a unique, inexpensive, non-invasive method of testing for active inflammatory disease. They can be used to screen for IBD and as a surrogate marker of mucosal healing they are useful in monitoring the response to therapeutic intervention or surgery. They may also predict the clinical course of the disease. This clinical review aims to discuss the current evidence, limitations and potential future uses of these biomarkers in IBD.
authors.affiliation: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
authors.forename: C A
authors.initials: CA
authors.lastname: Lamb
authors.forename: J C
authors.initials: JC
authors.lastname: Mansfield
references.citation: J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):414-22
references.pmid: 17414136
references.citation: Dig Liver Dis. 2004 Jul;36(7):467-70
references.pmid: 15285526
references.citation: Scand J Gastroenterol. 1992 Sep;27(9):793-8
references.pmid: 1411288
references.citation: Am J Gastroenterol. 2003 Jun;98(6):1309-14
references.pmid: 12818275
references.citation: Gastroenterology. 2004 May;126(5):1280-6
references.pmid: 15131788
references.citation: Dig Dis Sci. 2004 Jun;49(6):1036-9
references.pmid: 15309897
references.citation: Inflamm Bowel Dis. 2008 Jan;14(1):40-6
references.pmid: 18022866
references.citation: Gut. 2005 Mar;54(3):364-8
references.pmid: 15710984
references.citation: Gastroenterology. 1983 Dec;85(6):1333-9
references.pmid: 6628930
references.citation: Gastroenterology. 2003 Jun;124(7):1728-37
references.pmid: 12806605
references.citation: Scand J Gastroenterol. 1983 Oct;18(7):907-12
references.pmid: 6676924
references.citation: Gastroenterology. 1976 Mar;70(3):439-44
references.pmid: 1248701
references.citation: Dig Liver Dis. 2003 Sep;35(9):642-7
references.pmid: 14563186
references.citation: Gut. 2000 Oct;47(4):506-13
references.pmid: 10986210
references.citation: Aliment Pharmacol Ther. 2004 Sep 15;20(6):615-21
references.pmid: 15352909
references.citation: Scand J Gastroenterol. 2004 Oct;39(10):1017-20
references.pmid: 15513345
references.citation: BMJ. 2010 Jul 15;341:c3369
references.pmid: 20634346
references.citation: Clin Chem. 2003 Jun;49(6 Pt 1):861-7
references.pmid: 12765980
references.citation: Dis Colon Rectum. 2007 Oct;50(10):1697-706
references.pmid: 17762964
references.citation: Endocr Metab Immune Disord Drug Targets. 2007 Mar;7(1):1-5
references.pmid: 17346198
references.citation: Inflamm Bowel Dis. 2009 Sep;15(9):1295-301
references.pmid: 19340881
references.citation: Int J Colorectal Dis. 2007 Apr;22(4):429-37
references.pmid: 16838143
references.citation: Br J Surg. 2009 Jun;96(6):663-74
references.pmid: 19384912
references.citation: Gastroenterology. 2002 Aug;123(2):450-60
references.pmid: 12145798
references.citation: Intern Med. 2000 Oct;39(10):778-82
references.pmid: 11030199
references.citation: Scand J Gastroenterol. 1999 Jan;34(1):50-4
references.pmid: 10048733
references.citation: J Pediatr Gastroenterol Nutr. 2001 Jul;33(1):14-22
references.pmid: 11479402
references.citation: Am J Gastroenterol. 2007 Apr;102(4):803-13
references.pmid: 17324124
references.citation: Dis Colon Rectum. 2007 Jun;50(6):861-9
references.pmid: 17473939
references.citation: Inflamm Bowel Dis. 2008 Oct;14(10):1392-8
references.pmid: 18484671
references.citation: J Clin Microbiol. 1992 May;30(5):1238-42
references.pmid: 1583125
references.citation: Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24
references.pmid: 18799360
references.citation: J Pediatr Gastroenterol Nutr. 2005 Apr;40(4):450-5
references.pmid: 15795593
references.citation: Blood. 2000 Oct 15;96(8):2664-72
references.pmid: 11023496
references.citation: Aliment Pharmacol Ther. 2010 Jun;31(12):1365-70
references.pmid: 20331581
references.citation: Clin Chem Lab Med. 2008;46(9):1275-80
references.pmid: 18597588
references.citation: Gastroenterology. 1986 May;90(5 Pt 1):1121-8
references.pmid: 3956932
references.citation: Gastroenterology. 2000 Jul;119(1):15-22
references.pmid: 10889150
references.citation: Inflamm Bowel Dis. 2008 Jan;14(1):32-9
references.pmid: 17924558
references.citation: Aliment Pharmacol Ther. 2007 Oct 1;26(7):1035-42
references.pmid: 17877510
references.citation: Am J Gastroenterol. 2010 Aug;105(8):1788, 1789-94; quiz 1795
references.pmid: 20389294
references.citation: QJM. 2005 Jun;98(6):435-41
references.pmid: 15879440